# Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children

> **NCT03039699** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 259 (actual)

## Conditions studied

- Viral Intestinal Infection

## Interventions

- **DRUG:** Ergoferon
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03039699
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-23
- **Primary completion:** 2019-06-01
- **Final completion:** 2019-06-01
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03039699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03039699, "Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03039699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*